Skip to Main Content

Paper Details

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy.
Cancer Cell
138
2019
PARP, WEE1, cancer, cancer cells, normal and malignant cells, normal cells, ovarian cancer, patient-derived xenograft models, poly(ADP-ribose), poly(ADP-ribose) polymerase, tumor
Author NameAffiliation
Daniel J McGrailThe University of Texas MD Anderson Cancer Center
Zhenlin JuThe University of Texas MD Anderson Cancer Center
Yiling LuThe University of Texas MD Anderson Cancer Center
Yongsheng LiThe University of Texas MD Anderson Cancer Center
Nidhi SahniThe University of Texas MD Anderson Cancer Center
Beom-Jun KimThe University of Texas MD Anderson Cancer Center
Beom-Jun KimThe University of Texas MD Anderson Cancer Center
Ken ChenThe University of Texas MD Anderson Cancer Center
Shiaw-Yih LinThe University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center, Oregon Health and Sciences University, USA Knight Cancer Institute
Gordon B MillsThe University of Texas MD Anderson Cancer Center, Oregon Health and Sciences University, USA Knight Cancer Institute
  • 1 - 11

Datasets

Release 1.2